M&A Deal Summary

PRA Health Sciences Acquires Pharma Bio-Research BV

On June 19, 2006, PRA Health Sciences acquired life science company Pharma Bio-Research BV from HgCapital for 85M EUR

Acquisition Highlights
  • This is PRA Health Sciences’ 1st transaction in the Life Science sector.
  • This is PRA Health Sciences’ largest (disclosed) transaction.
  • This is PRA Health Sciences’ 1st transaction in the Netherlands.

M&A Deal Summary
Date 2006-06-19
Target Pharma Bio-Research BV
Sector Life Science
Buyer(s) PRA Health Sciences
Sellers(s) HgCapital
Deal Type Add-on Acquisition
Deal Value 85M EUR

Target

Pharma Bio-Research BV

Zuidlaren, Netherlands
PBR is a market leader in the management of complex Phase I and Phase IIa clinical trials of new drugs on behalf of the world's top pharmaceutical and biotechnology firms.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PRA Health Sciences

Raleigh, North Carolina, United States

website

Category Company
Founded 1976
Sector Life Science
Employees17,500
Revenue 3.1B USD (2019)
DESCRIPTION
PRA Health Sciences' corporate headquarters in Raleigh, North Carolina.
PRA Health Sciences' corporate headquarters in Raleigh, North Carolina.

PRA Health Sciences, Inc. is an international clinical research organization. PRA provides services on a contract basis to the pharmaceutical and biotechnology industries. Comprehensive services include the filing of Investigational New Drug (IND) and similar regulatory applications, management and implementation of Phase I through IV clinical trials, preparation and submission of New Drug Applications (NDAs), and post-marketing surveillance on an international basis. PRA was formed in 1976 and is based in Raleigh, North Carolina.

DEAL STATS #
Overall 2 of 8
Sector (Life Science) 1 of 3
Type (Add-on Acquisition) 2 of 8
Country (Netherlands) 1 of 1
Year (2006) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-06-17 CroMedica International

Victoria, British Columbia, Canada

CroMedica International, Inc, a worldwide clinical research organization (CRO) headquartered in Canada.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-20 Kinship Technologies

Chennai, India

Kinship Technologies is a Chennai, India-based software developer and services company.

Buy -

Seller(S) 1

SELLER

HgCapital

London, United Kingdom

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2000
PE ASSETS 65.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

HgCapital is a European private equity firm focused on a wide range of transactions including public-to-private leveraged buy-outs, management buy-ins, divestitures, and turnarounds. Broad sectors of interest include consumer and leisure, healthcare, industrials, services, technology, media, and renewable energy. The Firm will consider both majority and minority investment positions. HgCapital is the successor to Mercury Capital Partners, a former unit of Merill Lynch which was spun out by management in 2000. HgCapital has offices in London and Munich.

DEAL STATS #
Overall 6 of 86
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 41
Country (Netherlands) 1 of 7
Year (2006) 2 of 3
Size (of disclosed) 29 of 33
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-03 Travelsphere Holdings

Leicestershire, United Kingdom

Travelsphere is the UK's largest direct-sell, overseas escorted holiday provider for the 45+ age group.

Sell £155M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-07-06 Castlebeck

County Durham, United Kingdom

Castlebeck is a provider of specialist healthcare and rehabilitation services for adults and adolescents with learning disabilities and severely challenging behaviours. It operates specialist hospitals and care homes across the Midlands, North East of England and Scotland.

Sell £255M
Mergr

Product

Company

Legal